Second line therapy in type 2 diabetes: legacy effect activation

Type 2 diabetes causes hundred thousand deaths worldwide every year. Though new antidiabetic drugs appear annually and new classes of drugs are invented approximately every ten years still a lot of type 2 diabetic patients remain to be out of the target glycemic levels. According to most of the gui...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ekaterina A. Shestakova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2017
Materias:
Acceso en línea:https://doaj.org/article/effa23afa59d45be871c37adb10145d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares